文献速递免疫规划传染病防控与疫情报告

2014年葡萄牙人群对新漂移甲型H3流感病毒的交叉保护及季节性流感保护性抗体流行率

Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
PubMed 文献 · Vaccine · 2017-03-18

该研究基于2014年6月在葡萄牙采集的626份便利样本血清,采用血凝抑制试验检测各年龄组、性别和地区人群对季节性流感疫苗株及新A(H3)漂移株的抗体。结果显示A(H3)和A(H1)pdm09血清阳性率高于B型,A(H3)血清阳性者对新漂移A(H3)病毒的交叉保护较低(46%),甲型H1pdm09和H3血清保护在14岁以下最高。

要点

  • A(H3)血清阳性者对新A(H3)漂移病毒的交叉保护较低,为46%。
  • 甲型H1pdm09和H3血清保护在14岁以下人群最高。
  • 葡萄牙大陆血清保护率从北到南呈显著下降趋势。

核心结论

  • 较低的血清保护会增加下一个冬季流感感染的风险,血清流行病学研究可为决策者提供疫苗接种和额外预防措施需求的依据。

研究设计与样本

  • 横断面研究,基于2014年6月采集的626份便利样本血清,覆盖葡萄牙所有年龄组、性别和行政卫生区域。
  • 采用血凝抑制试验评估对季节性和新A(H3)漂移流感病毒的抗体滴度。

主要发现

  • 甲型H3血清阳性率为39.9%(95%CI:36.2-43.8),甲型H1pdm09为29.7%(95%CI:26.3-33.4),均高于乙型流感。
  • A(H3)血清阳性个体对新A(H3)漂移病毒的交叉保护为46%。
  • 甲型H1pdm09和H3血清保护在14岁以下人群最高;乙型保护性抗体在65岁以上人群最高,尤其B/Yamagata谱系为33.3%(95%CI:25.7-41.9)。
  • 女性流感血清阳性率高于男性,但无统计学显著性。
  • 葡萄牙大陆血清保护率从北到南呈显著下降趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Immune profile for influenza viruses is highly changeable over time. Serological studies can assess the prevalence of influenza, estimate the risk of infection, highlight asymptomatic infection rate and can also provide data on vaccine coverage. The aims of the study were to evaluate pre-existing cross-protection against influenza A(H3) drift viruses and to assess influenza immunity in the Portuguese population. MATERIALS AND METHODS: We developed a cross-sectional study based on a convenience sample of 626 sera collected during June 2014, covering all age groups, both gender and all administrative health regions of Portugal. Sera antibody titers for seasonal and new A(H3) drift influenza virus were evaluated by hemagglutination inhibition assay (HI). Seroprevalence to each seasonal influenza vaccine strain virus and to the new A(H3) drift circulating strain was estimated by age group, gender and region and compared with seasonal influenza-like illness (ILI) incidence rates before and after the study period. RESULTS: Our findings suggest that seroprevalences of influenza A(H3) (39.9%; 95% CI: 36.2-43.8) and A(H1)pdm09 (29.7%; 95% CI: 26.3-33.4) antibodies were higher than for influenza B, in line with high ILI incidence rates for A(H3) followed by A(H1)pdm09, during 2013/2014 season. Low pre-existing cross-protection against new A(H3) drift viruses were observed in A(H3) seropositive individuals (46%). Both against influenza A(H1)pdm09 and A(H3) seroprotection was highest in younger than 14-years old. Protective antibodies against influenza B were highest in those older than 65years old, especially for B/Yamagata lineage, 33.3% (95% CI: 25.7-41.9). Women showed a high seroprevalence to influenza, although without statistical significance, when compared to men. A significant decreasing trend in seroprotection from north to south regions of Portugal mainland was observed. CONCLUSIONS: Our results emphasize that low seroprotection increases the risk of influenza infection in the following winter season. Seroepidemiological studies can inform policy makers on the need for vaccination and additional preventive measures.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Guiomar R, Pereira da Silva S, Conde P, et al. Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal. Vaccine. 2017. PMID: 28318771. doi:10.1016/j.vaccine.2017.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。